Korean biotech firm takes second shot at Singapore backdoor listing
Add BT as a preferred sourceSingapore
A SOUTH KOREAN steelmaker controls a firm that makes kimchi lactobacillus (lactic acid bacteria) is trying again to secure a listing for the latter biotech firm by a backdoor route.
Stainless steel manufacturer Kossen, a key shareholder of BiogenicsKorea, has signed an implementation agreement with Epicentre Holdings (the former authorised Apple retailer) and Tardis Capital, said Epicentre's judicial managers (JMs) on Wednesday.
TRENDING NOW
Electricity tariff to rise significantly from July despite Iran deal: EMA
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Onitsuka Tiger pivots from Asics stripes to tap luxury market
